Sapphire Pharma Inc. is an early-stage global pharmaceutical company redefining healthcare through innovation, affordability, and strategic partnerships. With a focus on key therapeutic areas such as infectious diseases, autoimmune disorders, and women’s health, we are addressing critical unmet medical needs on a global scale.
By leveraging cutting-edge drug development, efficient pharmaceutical manufacturing, and streamlined distribution processes, Sapphire Pharma ensures the delivery of high-quality, accessible medicines. Our commitment to healthcare equity and patient outcomes drives us to create impactful solutions that transform lives and shape the future of the pharmaceutical industry.
Follow us to stay updated on our journey to advancing medical innovation and expanding access to essential treatments worldwide.
Company Details
- Employees
- 2
- Founded
- -
- Address
- 216 Stelton Rd, Piscataway,new Jersey 08854,united States
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.sapphirepharma.us/
- Keywords
- Mumbai.
- HQ
- Piscataway, New Jersey
Sapphire Pharma Inc Questions
Sapphire Pharma Inc's website is https://www.sapphirepharma.us/
Sapphire Pharma Inc's LinkedIn profile is https://www.linkedin.com/company/sapphire-pharma-inc
Sapphire Pharma Inc has
2 employees.
View email and phone details for 2
employees at Sapphire Pharma Inc.
Sapphire Pharma Inc's industry is
Pharmaceutical Manufacturing
Sapphire Pharma Inc's top competitors are
Feelbetr Health,
The Female Body,
Alianza Delaware,
Medicines For All Institute,
Us Supercharge,
Eli Lilly And Company,
Mfbs Digital Marketing Studio,
Neuroglympse,
Financial Planning Association Of New Jersey,
Innovest Investment Inc..
Sapphire Pharma Inc's categories are Pharmaceutical Manufacturing
Sapphire Pharma Inc's founding year is 2017
